TAM
GTHX

Tiverton Asset Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Tiverton Asset Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-5,000
Closed -$186K – 525
2018
Q1 		$186K Buy
+5,000
New +$133K 0.01% 329

Other funds holding GTHX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Tiverton Asset Management's GTHX Position: Q2 2018 in Review

Tiverton Asset Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2018, closing a stake of 5,000 shares — an estimated $186K sold.

Tiverton Asset Management first reported a position in GTHX in Q1 2018 and held it in 1 quarter. The position peaked at $186K in Q1 2018. 95 funds tracked by Wall St. Rank hold GTHX as of Q2 2018.

  • Tiverton Asset Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Tiverton Asset Management sold 5,000 G1 Therapeutics, Inc. Common Stock shares in Q2 2018, an estimated $186K.
  • Tiverton Asset Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • Tiverton Asset Management's G1 Therapeutics, Inc. Common Stock position peaked at $186K in Q1 2018.
  • 95 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2018.

Based on Tiverton Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.